Andy Johnson is a litigator who enjoys helping his clients find solutions to their complex business problems. Sometimes these problems can only be solved through a jury’s verdict and the review of an appellate court (seeThomas Jefferson Foundation, Inc. v. Jordan, 200 So. 3d 645 (Ala. 2016)). Other times these problems are resolved through a court’s intervention making a trial unnecessary (seeMoore Oil Co, Inc. v D&D Oil Co., Inc., 747 F.Supp.2d 1280 (N.D. Ala. 2010), or through arbitration, mediation, or settlement. Andy believes that each case is different, and there is no one-size-fits-all approach to a business or legal problem.
Andy has worked with clients to resolve their specific legal issues in a variety of business areas. A significant portion of his practice has consisted of the defense of claims against companies that invent, design, manufacture and market complex products, with a focus on pharmaceutical or drug and device litigation. As an example, Andy was appointed as the co-defense liaison counsel in In Re Chantix (Varenicline) Products LiabilityLitigation MDL 2092. His work in the life sciences arena has encompassed the representation of Pfizer, Bayer, Merck and Guidant among others, and has spanned over 15 years.
Andy’s work for manufacturers has also involved tires (Cooper Tire and Goodyear) and construction materials (Valmont Newmark). This representation has spanned many aspects of litigation, from defense of product liability claims to protection of trade secrets and commercial disputes with other corporations.
Articles in the National Law Review database by Andy Johnson